Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cresco Labs (CRLBF) EBIT (2020 - 2025)

Historic EBIT for Cresco Labs (CRLBF) over the last 6 years, with Q3 2025 value amounting to $17.8 million.

  • Cresco Labs' EBIT fell 3232.36% to $17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.0 million, marking a year-over-year decrease of 4176.28%. This contributed to the annual value of $107.3 million for FY2024, which is 22216.85% up from last year.
  • Per Cresco Labs' latest filing, its EBIT stood at $17.8 million for Q3 2025, which was down 3232.36% from $16.1 million recorded in Q2 2025.
  • In the past 5 years, Cresco Labs' EBIT registered a high of $32.4 million during Q2 2024, and its lowest value of -$264.0 million during Q3 2021.
  • Moreover, its 5-year median value for EBIT was $16.2 million (2021), whereas its average is -$12.3 million.
  • Data for Cresco Labs' EBIT shows a peak YoY increase of 462857.14% (in 2021) and a maximum YoY decrease of 115882.49% (in 2021) over the last 5 years.
  • Over the past 5 years, Cresco Labs' EBIT (Quarter) stood at $15.6 million in 2021, then crashed by 1022.28% to -$143.5 million in 2022, then skyrocketed by 118.89% to $27.1 million in 2023, then fell by 28.39% to $19.4 million in 2024, then decreased by 8.13% to $17.8 million in 2025.
  • Its last three reported values are $17.8 million in Q3 2025, $16.1 million for Q2 2025, and $13.6 million during Q1 2025.